fda category 2 bulk drug substances bpc-157 compounding list Deep Dive: Regulatory Status of Popular Compounded Peptides – Holt Law You may have heard buzz
You may have heard buzz about 14 peptides potentially returning to legal compounding. Here's what we know: HHS Secretary RFK Jr. stated his intention to move these peptides from FDA Category 2 FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner RFK Jr.'s peptide push could unleash risky drugs STAT First Opinion
Pay in 4 interest-free payments of $7.03 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4


